Business · 21/06/1999Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 55 ANDA's at Steris Laboratories' Request
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 55 abbreviated new drug applications (ANDA's) at the request of Steris Laboratories, Inc., which notified the agency that the drug products are no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →